CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway
about
Mechanisms of TGFβ-Induced Epithelial-Mesenchymal TransitionTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsGender differences in transcriptional signature of developing rat testes and ovaries following embryonic exposure to 2,3,7,8-TCDDDeficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.Genome-wide RNA-Sequencing analysis identifies a distinct fibrosis gene signature in the conjunctiva after glaucoma surgeryCCN1/CYR61: the very model of a modern matricellular protein.A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsTGF-β signaling in breast cancer cell invasion and bone metastasis.CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.CCN5/WISP-2: A micromanager of breast cancer progressionEarly gene expression in salivary gland after isoproterenol treatment.WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4.Restricted adipogenesis in hypertrophic obesity: the role of WISP2, WNT, and BMP4Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistanceMolecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus.ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.Emerging roles of CCN proteins in vascular development and pathology.Human pancreatic cancer progression: an anarchy among CCN-siblings.Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression.Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN familyCCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.CCN5/WISP2 and metabolic diseases.Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis.CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
P2860
Q26745545-A40222D8-8D1D-4422-A2DB-E01B7E820BD2Q28254386-36E9FB21-4ADB-41AD-AF4F-B322E8A24870Q28727353-7966916D-F1C5-4E01-94BD-D0599D2B1E22Q33681837-2060817C-ED53-4656-ACA2-DC7C41042691Q33912109-2A3AE043-BFDB-431B-B90B-32AE83D775D3Q34027926-B2D2C9D6-1336-4DC5-8668-416322A07226Q34364398-A84E6A0E-6586-43FB-B57A-1BE839444441Q34985004-FAEFA0C5-EE7D-4196-8E8C-656C6A5EDC68Q35827652-61DB0CA5-A640-4985-98DD-56770FBD717AQ36010510-379FE987-38FD-4475-A70C-20DC715329FCQ36206162-DC98CC49-C0D1-4ACB-A99F-B01E945D5CF2Q36616934-1C706CE2-E89D-4D53-BCC3-4B8CABF34656Q37110526-279F6009-3F10-4FA2-B58E-51C5A280E51DQ37549104-18C7DB42-335B-4FBB-BEFC-A088EA53C83BQ37668148-1B0BFABC-C7D2-4478-82F7-3D5CF817D3D0Q37728750-3CDFEA61-0399-43FC-87B7-C0E8C306D240Q38023321-77F4BCBA-9F50-482E-91AB-48CE763346E2Q38323850-E007934F-8408-4824-B660-642423BEF6DEQ38563527-672D20B8-0E72-4358-BF3B-B54B0813D957Q38730332-29F9AC6B-0F5A-48BE-A447-7EA2087F23FAQ38848476-83C78F11-12BA-46FE-9182-40933F83CCBAQ38931858-B5313C94-CB89-4C14-B9C2-C93F8B6ABFCAQ38984559-14692C1F-8E38-48E5-97B3-FD4485C0458DQ41516168-1D96180B-7AD7-4DDB-A5AE-F85BF68558F8Q44786986-1724EC73-930D-4E2B-85F7-47A4BB1C45C5Q47244341-C73FF26D-8974-491E-92BF-038927361D07Q48261660-87DD343E-6672-4B34-8BDD-66F510CA5E40Q50069018-85E4944A-0F69-4BA2-845F-8AE62B240E07Q53404791-85559BAF-C56B-41F8-B91F-D7AB32369336
P2860
CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@ast
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@en
type
label
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@ast
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@en
prefLabel
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@ast
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@en
P2093
P2860
P356
P1476
CCN5, a novel transcriptional ...... wth factor β signaling pathway
@en
P2093
Céline Prunier
Gérard Redeuilh
Joël Lachuer
Kathleen Lambein
Michèle Sabbah
Nathalie Ferrand
Nicolas Nazaret
Olivier De Wever
Sylvie Dumont
Virginie Megalophonos
P2860
P304
P356
10.1128/MCB.01316-10
P407
P577
2011-01-24T00:00:00Z